Unusual options activity is one of the most reliable pre-event signals available to retail traders. Large sweeps, deep out-of-the-money call purchases, and unusually high put/call ratios often reflect institutional positioning ahead of events that aren't yet public — earnings beats, FDA decisions, acquisitions, or government contract awards. The tools that surface this activity in real time give retail a window into smart-money conviction.
Not all options activity is signal. The challenge with options flow analysis is separating institutional directional bets from hedges, delta-neutral strategies, and retail speculation. The signals that carry the most information are:
Members of Congress are legally permitted to trade individual securities, including options, based on information they receive in their governmental capacity — provided the trading isn't based on non-public material information obtained through their official duties (the STOCK Act prohibits this in theory, but enforcement has been minimal). In practice, congressional options trading in sectors with relevant oversight often correlates with upcoming regulatory or legislative outcomes.
Key patterns to watch:
StonkWhisper's intel feeds aggregate unusual options activity from live market data alongside all congressional trading disclosures from the STOCK Act database, updated daily as new reports are filed. The whale tracking feed identifies large institutional options sweeps, filters out likely delta-neutral positioning, and surfaces the directional bets that carry meaningful signal about upcoming events.
Congressional trade disclosures appear in StonkWhisper's Wire the day they're filed — not weeks later when financial media picks them up. For options specifically, congressional purchases of short-dated calls are flagged with the committee membership of the filing member, providing context for what information they may have had access to.
Access Options Flow & Congressional Trades →Biotech options activity around FDA decision dates is one of the most studied areas of pre-event positioning. PDUFA dates are public, so there's no insider-trading issue with accumulating options positions ahead of a known FDA review date. The question is which direction the institutional money is positioning — and large unusual options purchases in specific strike/expiry combinations can give directional clues.
Patterns that carry higher signal in biotech options flow:
Options flow without catalyst context is incomplete. BiotechSigns provides the forward catalyst calendar — PDUFA dates, trial readouts, advisory committee meetings — that gives options activity its interpretive frame. When StonkWhisper shows unusual call buying in a biotech name and BiotechSigns shows a PDUFA date 15 days out, the combination is substantially more actionable than either signal alone.
Add Catalyst Context →The put/call ratio measures total put volume divided by call volume for a given stock or index. Extremely high put/call ratios in individual stocks sometimes signal institutional hedging ahead of known negative events — but they can also be a contrarian bullish signal when they reflect excessive retail fear rather than informed positioning.
The distinction matters: a high put/call ratio driven by large institutional put sweeps (visible in the flow data) is bearish confirmation. A high ratio driven by millions of small retail put purchases is potentially a contrarian setup — the "fear trade" that sophisticated buyers fade.
TraderTools Pro bundles StonkWhisper's options flow and congressional trading with BiotechSigns' catalyst calendar, DilutionWatch's SEC filing monitoring, and Contract Trader's procurement intelligence — $99/mo for Founding Members.
Get the Full StackTraderTools Pro, DilutionWatch, BiotechSigns, StonkWhisper, ChainSifter, and Contract Trader are research platforms providing data for informational and educational purposes only. Nothing on any platform constitutes investment, financial, legal, medical, or procurement advice of any kind. All trading and investment decisions are made solely at your own risk. Past performance is not indicative of future results. · Full Disclaimer · Terms of Service